Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (401-410 of 494) with videos related to

Pageof 50
Sort By:
Scientific Reports|May 23, 2026
Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancerNaoya Itoh, Takanori Kawabata, Nana Akazawa, et al.
Research Square|November 28, 2024
Evolutionary loss of an antibiotic efflux pump increases <i>Pseudomonas aeruginosa</i> quorum sensing mediated virulence <i>in vivo</i>Sheryl E Fernandes, Humberto Ortega, Mylene Vaillancourt, et al.
Nature Communications|September 25, 2025
Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivoSheryl E Fernandes, Humberto Ortega, Mylene Vaillancourt, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2017
Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coliErik H Klontz, Adam D Tomich, Sebastian Günther, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimenRyan K Shields, Eun J Kwak, Brian A Potoski, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
High-level ceftazidime-avibactam resistance in <i>Escherichia coli</i> conferred by the novel plasmid-mediated beta-lactamase CMY-185 variantWilliam C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, et al.
Biochemistry|November 27, 2009
Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2Andrea Endimiani, Yohei Doi, Christopher R Bethel, et al.
Lancet (London, England)|May 14, 2026
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trialSatoshi Takahashi, Kazuhiro Tateda, Katsunori Yanagihara, et al.
Emerging Microbes & Infections|April 19, 2022
MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteriaSiyuan Feng, Wanfei Liang, Jiachen Li, et al.
Pageof 50

Showing results (401-410 of 494) with videos related to

Sort By:
Pageof 50
Scientific Reports|May 23, 2026
Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancerNaoya Itoh, Takanori Kawabata, Nana Akazawa, et al.
Research Square|November 28, 2024
Evolutionary loss of an antibiotic efflux pump increases <i>Pseudomonas aeruginosa</i> quorum sensing mediated virulence <i>in vivo</i>Sheryl E Fernandes, Humberto Ortega, Mylene Vaillancourt, et al.
Nature Communications|September 25, 2025
Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivoSheryl E Fernandes, Humberto Ortega, Mylene Vaillancourt, et al.
Antimicrobial Agents and Chemotherapy|September 7, 2017
Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coliErik H Klontz, Adam D Tomich, Sebastian Günther, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimenRyan K Shields, Eun J Kwak, Brian A Potoski, et al.
Biorxiv : the Preprint Server for Biology|February 13, 2023
High-level ceftazidime-avibactam resistance in <i>Escherichia coli</i> conferred by the novel plasmid-mediated beta-lactamase CMY-185 variantWilliam C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2023
Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum β-lactamase-producing <i>Escherichia coli</i>Kayoko Hayakawa, Yasufumi Matsumura, Kohei Uemura, et al.
Biochemistry|November 27, 2009
Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2Andrea Endimiani, Yohei Doi, Christopher R Bethel, et al.
Lancet (London, England)|May 14, 2026
Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trialSatoshi Takahashi, Kazuhiro Tateda, Katsunori Yanagihara, et al.
Emerging Microbes & Infections|April 19, 2022
MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteriaSiyuan Feng, Wanfei Liang, Jiachen Li, et al.
Pageof 50